Incidence and timing of infusion-related reactions in patients with mucopolysaccharidosis type II (Hunter syndrome) on idursulfase therapy in the real-world setting: a perspective from the Hunter Outcome Survey (HOS)

Bk Burton; Dah Whiteman; Claudio Feliciani

doi:10.1016/j.ymgme.2011.02.018

Incidence and timing of infusion-related reactions in patients with mucopolysaccharidosis type II (Hunter syndrome) on idursulfase therapy in the real-world setting: a perspective from the Hunter Outcome Survey (HOS)

Bk Burton, Dah Whiteman, Claudio Feliciani

Risultato della ricerca: Contributo in rivista › Articolo in rivista

41 Citazioni (Scopus)

Abstract

To evaluate the occurrence of infusion-related reactions (IRRs) in patients with mucopolysaccharidosis type II (MPS II) receiving idursulfase enrolled in the observational database HOS - the Hunter Outcome Survey.

Lingua originale	English
pagine (da-a)	113-120
Numero di pagine	8
Rivista	Molecular Genetics and Metabolism
Volume	103
DOI	https://doi.org/10.1016/j.ymgme.2011.02.018
Stato di pubblicazione	Pubblicato - 2011
Pubblicato esternamente	Sì

Keywords

Adolescent
Adrenal Cortex Hormones
Adult
Anti-Allergic Agents
Antibodies, Neutralizing
Child
Child, Preschool
Data Collection
Databases, Factual
Enzyme Replacement Therapy
Humans
Hypersensitivity
Iduronate Sulfatase
Incidence
Infant
Mucopolysaccharidosis II
Time Factors
Treatment Outcome
Young Adult

Accesso al documento

10.1016/j.ymgme.2011.02.018

Altri file e collegamenti

Link a IRIS PubliCatt

Fingerprint

Entra nei temi di ricerca di 'Incidence and timing of infusion-related reactions in patients with mucopolysaccharidosis type II (Hunter syndrome) on idursulfase therapy in the real-world setting: a perspective from the Hunter Outcome Survey (HOS)'. Insieme formano una fingerprint unica.

Cita questo

@article{1d735a2c3845408ba3cfb320272df90f,

title = "Incidence and timing of infusion-related reactions in patients with mucopolysaccharidosis type II (Hunter syndrome) on idursulfase therapy in the real-world setting: a perspective from the Hunter Outcome Survey (HOS)",

abstract = "To evaluate the occurrence of infusion-related reactions (IRRs) in patients with mucopolysaccharidosis type II (MPS II) receiving idursulfase enrolled in the observational database HOS - the Hunter Outcome Survey.",

keywords = "Adolescent, Adrenal Cortex Hormones, Adult, Anti-Allergic Agents, Antibodies, Neutralizing, Child, Child, Preschool, Data Collection, Databases, Factual, Enzyme Replacement Therapy, Humans, Hypersensitivity, Iduronate Sulfatase, Incidence, Infant, Mucopolysaccharidosis II, Time Factors, Treatment Outcome, Young Adult, Adolescent, Adrenal Cortex Hormones, Adult, Anti-Allergic Agents, Antibodies, Neutralizing, Child, Child, Preschool, Data Collection, Databases, Factual, Enzyme Replacement Therapy, Humans, Hypersensitivity, Iduronate Sulfatase, Incidence, Infant, Mucopolysaccharidosis II, Time Factors, Treatment Outcome, Young Adult",

author = "Bk Burton and Dah Whiteman and Claudio Feliciani",

year = "2011",

doi = "10.1016/j.ymgme.2011.02.018",

language = "English",

volume = "103",

pages = "113--120",

journal = "Molecular Genetics and Metabolism",

issn = "1096-7206",

publisher = "Academic Press Inc.",

}

Incidence and timing of infusion-related reactions in patients with mucopolysaccharidosis type II (Hunter syndrome) on idursulfase therapy in the real-world setting: a perspective from the Hunter Outcome Survey (HOS). / Burton, Bk; Whiteman, Dah; Feliciani, Claudio.
In: Molecular Genetics and Metabolism, Vol. 103, 2011, pag. 113-120.

Risultato della ricerca: Contributo in rivista › Articolo in rivista

TY - JOUR

T1 - Incidence and timing of infusion-related reactions in patients with mucopolysaccharidosis type II (Hunter syndrome) on idursulfase therapy in the real-world setting: a perspective from the Hunter Outcome Survey (HOS)

AU - Burton, Bk

AU - Whiteman, Dah

AU - Feliciani, Claudio

PY - 2011

Y1 - 2011

N2 - To evaluate the occurrence of infusion-related reactions (IRRs) in patients with mucopolysaccharidosis type II (MPS II) receiving idursulfase enrolled in the observational database HOS - the Hunter Outcome Survey.

AB - To evaluate the occurrence of infusion-related reactions (IRRs) in patients with mucopolysaccharidosis type II (MPS II) receiving idursulfase enrolled in the observational database HOS - the Hunter Outcome Survey.

KW - Adolescent

KW - Adrenal Cortex Hormones

KW - Adult

KW - Anti-Allergic Agents

KW - Antibodies, Neutralizing

KW - Child

KW - Child, Preschool

KW - Data Collection

KW - Databases, Factual

KW - Enzyme Replacement Therapy

KW - Humans

KW - Hypersensitivity

KW - Iduronate Sulfatase

KW - Incidence

KW - Infant

KW - Mucopolysaccharidosis II

KW - Time Factors

KW - Treatment Outcome

KW - Young Adult

KW - Adolescent

KW - Adrenal Cortex Hormones

KW - Adult

KW - Anti-Allergic Agents

KW - Antibodies, Neutralizing

KW - Child

KW - Child, Preschool

KW - Data Collection

KW - Databases, Factual

KW - Enzyme Replacement Therapy

KW - Humans

KW - Hypersensitivity

KW - Iduronate Sulfatase

KW - Incidence

KW - Infant

KW - Mucopolysaccharidosis II

KW - Time Factors

KW - Treatment Outcome

KW - Young Adult

UR - http://hdl.handle.net/10807/7257

U2 - 10.1016/j.ymgme.2011.02.018

DO - 10.1016/j.ymgme.2011.02.018

M3 - Article

SN - 1096-7206

VL - 103

SP - 113

EP - 120

JO - Molecular Genetics and Metabolism

JF - Molecular Genetics and Metabolism

ER -